A detailed history of Royal Bank Of Canada transactions in Novo Cure LTD stock. As of the latest transaction made, Royal Bank Of Canada holds 22,312 shares of NVCR stock, worth $687,209. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,312
Previous 20,121 10.89%
Holding current value
$687,209
Previous $344,000 1.16%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.61 - $23.34 $34,201 - $51,137
2,191 Added 10.89%
22,312 $348,000
Q2 2024

Aug 14, 2024

SELL
$11.83 - $24.05 $13,308 - $27,056
-1,125 Reduced 5.3%
20,121 $344,000
Q1 2024

Nov 05, 2024

BUY
$12.42 - $17.29 $13,972 - $19,451
1,125 Added 5.59%
21,246 $332,000
Q1 2024

May 15, 2024

SELL
$12.42 - $17.29 $519,478 - $723,171
-41,826 Reduced 66.31%
21,246 $332,000
Q4 2023

Feb 14, 2024

BUY
$11.13 - $15.78 $556,410 - $788,873
49,992 Added 382.2%
63,072 $941,000
Q3 2023

Nov 14, 2023

BUY
$16.15 - $42.35 $17,102 - $44,848
1,059 Added 8.81%
13,080 $211,000
Q2 2023

Aug 14, 2023

BUY
$40.29 - $82.51 $207,453 - $424,843
5,149 Added 74.93%
12,021 $498,000
Q1 2023

May 15, 2023

SELL
$56.44 - $118.81 $704,032 - $1.48 Million
-12,474 Reduced 64.48%
6,872 $413,000
Q4 2022

Feb 14, 2023

SELL
$63.98 - $85.37 $47,025 - $62,746
-735 Reduced 3.66%
19,346 $1.42 Million
Q3 2022

Nov 14, 2022

BUY
$67.99 - $89.57 $100,149 - $131,936
1,473 Added 7.92%
20,081 $1.53 Million
Q2 2022

Aug 15, 2022

SELL
$56.6 - $89.9 $5,037 - $8,001
-89 Reduced 0.48%
18,608 $1.29 Million
Q1 2022

May 16, 2022

SELL
$60.15 - $84.52 $127,578 - $179,266
-2,121 Reduced 10.19%
18,697 $1.55 Million
Q4 2021

Feb 14, 2022

SELL
$75.08 - $121.99 $584,873 - $950,302
-7,790 Reduced 27.23%
20,818 $1.56 Million
Q3 2021

Nov 15, 2021

BUY
$116.17 - $194.55 $542,978 - $909,326
4,674 Added 19.53%
28,608 $3.32 Million
Q2 2021

Aug 16, 2021

BUY
$130.4 - $225.58 $3.12 Million - $5.4 Million
23,934 New
23,934 $5.31 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.